Physician Assistant, Medical · Dallas, TX
NPI
1104561281
Since 2022
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1018 N Zang Blvd Ste 110
Dallas, TX, 75208
Phone (972) 833-8091
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,045
198 services
Medicare patients, 2024
67
Average age 68
Drug cost, 2024
$2.1M
5,031 prescriptions
Company payments, 2025
$30K
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew J Garza was code 99214 (office e&m - established), 74 times for 60 patients. In total Andrew J Garza billed 198 services in 12 codes, and Medicare paid $9,045.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 74 | 60 | $70.15 | $5,191 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 63 | 45 | $9.59 | $604 |
| 99204 Office E&M - New | Office | 15 | 15 | $90.70 | $1,361 |
| 95251 Test - Miscellaneous | Office | 12 | 12 | $19.71 | $236 |
| 93922 Duplex Scan - Extremity Arteries | Office | 11 | 11 | $54.73 | $602 |
By year: 2022 $1,647 for 22 services; 2023 $3,255 for 60 services; 2024 $9,045 for 198 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andrew J Garza prescribed most often to Medicare patients was Atorvastatin Calcium, with 359 prescriptions and refills. In total Andrew J Garza wrote 5,031 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 359 | 742 | 111 | $2,194 |
| Levothyroxine Sodium Generic | 339 | 730 | 90 | $2,366 |
| Ozempic Semaglutide | 335 | 450 | 81 | $419K |
| Rosuvastatin Calcium Generic | 325 | 660 | 93 | $2,838 |
| Jardiance Empagliflozin | 236 | 389 | 57 | $229K |
| Amlodipine Besylate Generic | 163 | 287 | 43 | $711 |
| Lisinopril Generic | 151 | 323 | 44 | $794 |
| Ezetimibe Generic | 141 | 297 | 40 | $1,866 |
| Mounjaro Tirzepatide | 130 | 158 | 30 | $166K |
| Metformin Hcl Generic | 124 | 266 | 35 | $629 |
| Losartan Potassium Generic | 110 | 218 | 36 | $638 |
| Tresiba Flextouch U-200 Insulin Degludec | 108 | 226 | 35 | $143K |
| Farxiga Dapagliflozin Propanediol | 83 | 113 | 25 | $60K |
| Vascepa Icosapent Ethyl | 81 | 116 | 22 | $40K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 67 | 109 | 20 | $64K |
Brand drugs: 2,271 claims; generic drugs: 2,523 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew J Garza $30K ($30K in general payments such as food, travel and fees) from 30 companies. The largest payer was Insulet Corporation with $17K.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 44 | $17K |
| Medtronic, Inc. MDT | 46 | $6,455 |
| Corcept Therapeutics CORT | 37 | $1,536 |
| Abbott Laboratories ABT | 20 | $953 |
| Amgen Inc. AMGN | 55 | $897 |
| Xeris Pharmaceuticals, Inc. | 23 | $371 |
| Sequel Med Tech, LLC | 16 | $364 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 33 | $348 |
| Beta Bionics, Inc. BBNX | 7 | $319 |
| Novo Nordisk Inc NVO | 16 | $281 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.